ALB and COVID-19: Albumin’s potential in drug delivery, wound healing, antioxidant therapy, and tissue engineering continues to expand, particularly in the context of critical illnesses such as COVID-19, where the albumin globulin ratio has been identified as a predictor of disease severity and mortality.